Qube Research & Technologies (QRT)
PHAT icon

Qube Research & Technologies (QRT)’s Phathom Pharmaceuticals PHAT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-55,973
Closed -$455K – 3790
2024
Q4 		$455K Buy
+55,973
New +$693K ﹤0.01% 2521

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PHAT Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Phathom Pharmaceuticals (PHAT) in Q1 2025, closing a stake of 55,973 shares — an estimated $455K sold.

Qube Research & Technologies (QRT) first reported a position in PHAT in Q4 2024 and held it in 1 quarter. The position peaked at $455K in Q4 2024. 137 funds tracked by Wall St. Rank hold PHAT as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Phathom Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 55,973 Phathom Pharmaceuticals shares in Q1 2025, an estimated $455K.
  • Qube Research & Technologies (QRT) first reported a position in Phathom Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Phathom Pharmaceuticals position peaked at $455K in Q4 2024.
  • 137 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.